A monoclonal antibody (mAb, more rarely called moAb) is an antibody produced from a cell lineage made by cloning a unique white blood cell. All subsequent antibodies derived this way trace back to …

Jun 3, 2025 · The mAb (ibritumomab) delivers a radioactive substance (Yttrium-90) directly to cancer cells. Another example is Kadcyla, an mAb that is attached to a chemotherapy drug.

An open access journal publishing antibody research on topics including targets relevant to cancer and immune-mediated disorders, and antibody therapeutics.

Nov 16, 2021 · The generic names of the products often include the letters “mab” at the end of the name. What is the difference between monoclonal antibodies and polyclonal antibodies?

Bevacizumab (Avastin) is an mAb that targets a protein called VEGF that affects tumor blood vessel growth. It can cause side effects such as high blood pressure, bleeding, poor wound healing, blood …

Monoclonal antibody drugs are treatments that enlist your body's germ-fighting immune system against diseases, including cancer. If your health care provider recommends a monoclonal antibody drug as …

Apr 19, 2023 · A monoclonal antibody (mAb) is a type of immune protein produced in a lab that binds to a specific protein on a cell called an antigen. As with naturally occurring antibodies, monoclonal …

Jun 12, 2021 · In recent years, mAb products have dominated the biotherapeutics market, with hundreds of novel mAbs and mAb-like proteins now in clinical development for the treatment of diseases in …

Jun 26, 2023 · The nomenclature of mAbs depends on the origin of each respective mAb. Common suffixes include -omab, -ximab, -zumab, and -umab, representing murine, chimeric, humanized, and …

Jul 23, 2025 · You can often recognize these medicines because their names usually end with the suffix “-mab.” Today, mAbs are becoming popular as both research tools and research targets because …